Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting.

about

Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting.

Item

http://www.wikidata.org/entity/Q55263598

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Direct-Acting Antivirals in Ch ...... ion in Community Care Setting.

@en

Direct-Acting Antivirals in Ch ...... ion in Community Care Setting.

@nl

type

Item

label

Direct-Acting Antivirals in Ch ...... ion in Community Care Setting.

@en

Direct-Acting Antivirals in Ch ...... ion in Community Care Setting.

@nl

prefLabel

Direct-Acting Antivirals in Ch ...... ion in Community Care Setting.

@en

Direct-Acting Antivirals in Ch ...... ion in Community Care Setting.

@nl

P1476

Direct-Acting Antivirals in Ch ...... ion in Community Care Setting.

@en

P2093

Amrendra Kumar Mandal

http://www.w3.org/2001/XMLSchema#string

Arshpal Gill

http://www.w3.org/2001/XMLSchema#string

Binav Shrestha

http://www.w3.org/2001/XMLSchema#string

Debra Guss

http://www.w3.org/2001/XMLSchema#string

Jagannath Sherigar

http://www.w3.org/2001/XMLSchema#string

Mazin Khalid

http://www.w3.org/2001/XMLSchema#string

Mohammed Mansour

http://www.w3.org/2001/XMLSchema#string

Muhammad Rajib Hussain

http://www.w3.org/2001/XMLSchema#string

Smruti Mohanty

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology and genotype distribution of the hepatitis C virus infection

Sofosbuvir for previously untreated chronic hepatitis C infection

Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.

Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma.

Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.

Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study.

Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry.

P304

130-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/GR999W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pavani Garlapati

Osama Mukhtar

Vijay Gayam

P577

2018-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29707080

http://www.w3.org/2001/XMLSchema#string

P932

5916637

http://www.w3.org/2001/XMLSchema#string